Rare Liver Disease Drug Contenders Among Latest EU Filings
MAA For Bayer’s Finerenone Also Filed
Among the 13 new drug marketing applications that the European Medicines Agency has most recently accepted for review are two products that could become the first approved treatments for children with progressive familial intrahepatic cholestasis, a life-threatening disorder.
